Amelia Gallitano-Mendel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amelia Gallitano-Mendel has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
Amanda M. Maple
Department of Basic Medical Sciences, University of Arizona College of Medicine–Phoenix, Phoenix, USA
5 shared publications- Annika B. Ozols
University of Arizona College of Medicine - Phoenix
5 shared publications - Diano F. Marrone
Department of Psychology, Wilfrid Laurier University, Waterloo, ON, Canada
4 shared publications - Harris A. Gelbard
University of Rochester Medical Center
3 shared publications - Jeffrey Milbrandt
Department of Genetics, Washington University School of Medicine, St. Louis, USA
3 shared publications Ketan K. Marballi
Department of Basic Medical Sciences, University of Arizona College of Medicine - Phoenix, Phoenix, USA
3 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Springer Nature in BMC Biology
- Vol. 24 (1)
Activity-dependent increase of Egr1 in the hippocampus improves contextual memory in mice
- 28 July 2026
- Published by Springer Nature in BMC Biology
- Vol. 24 (1)
Open AccessActivity-dependent increase of Egr1 in the hippocampus improves contextual memory in mice
- Open Access
Activity of prefrontal cortex serotonin 2A receptor expressing neurons is necessary for the head-twitch response of mice to psychedelic drug DOI in a sex-dependent manner
Serotonin 2A receptors (5-HT 2A Rs) mediate the effects of psychedelic drugs. 5-HT 2A R agonists, such as (-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI), that produce a psychedelic experience in humans induce a head-twitch response (HTR) behavior in rodents. However, it is unknown whether the activity of 5-HT 2A R expressing neurons is sufficient to produce the HTR in the absence of an agonist, or in which brain region 5-HT 2A Rs control the HTR. Here, we use an optogenetic approach to examine whether activation of 5-HT 2A R expressing neurons in the mouse prefrontal cortex (PFC) is sufficient to induce HTRs alone, or may augment the HTR produced by DOI, and if inhibition of these neurons prevents DOI-induced HTRs in mice. We crossed Htr2a -Cre mice to Cre-dependent optogenetic lines Ai32 (channelrhodopsin) and Ai39 (halorhodopsin) to selectively activate and inhibit (respectively) 5-HT 2A R-expressing neurons in the PFC of adult mice. We found that optogenetic stimulation of PFC 5-HT 2A R expressing neurons in the absence of an agonist does not increase HTRs in mice. In both male and female Ai32 mice that received vehicle, there was no difference in HTRs in mice that expressed Htr2a -Cre compared with control mice, indicating that optogenetic activation of 5-HT 2A R+ cells in the PFC was not sufficient to produce HTRs in the absence of an agonist. In female mice, activation of PFC 5-HT 2A R expressing neurons augmented the HTR produced by DOI. However, this result was not seen in male mice. In contrast, inhibition of 5-HT 2A R expressing neurons in the PFC prevented the increase in HTR produced by DOI in male, but not in female, mice. Together, these findings suggest that activation of 5-HT 2A Rs in the PFC is not sufficient to induce HTRs in the absence of a 5-HT 2A R agonist but is necessary for induction of HTRs by a 5-HT 2A R agonist in a sex-dependent manner.
Open AccessActivity of prefrontal cortex serotonin 2A receptor expressing neurons is necessary for the head-twitch response of mice to psychedelic drug DOI in a sex-dependent manner
Serotonin 2A receptors (5-HT 2A Rs) mediate the effects of psychedelic drugs. 5-HT 2A R agonists, such as (-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI), that produce a psychedelic experience in humans induce a head-twitch response (HTR) behavior in rodents. However, it is unknown whether the activity of 5-HT 2A R expressing neurons is sufficient to produce the HTR in the absence of an agonist, or in which brain region 5-HT 2A Rs control the HTR. Here, we use an optogenetic approach to examine whether activation of 5-HT 2A R expressing neurons in the mouse prefrontal cortex (PFC) is sufficient to induce HTRs alone, or may augment the HTR produced by DOI, and if inhibition of these neurons prevents DOI-induced HTRs in mice. We crossed Htr2a -Cre mice to Cre-dependent optogenetic lines Ai32 (channelrhodopsin) and Ai39 (halorhodopsin) to selectively activate and inhibit (respectively) 5-HT 2A R-expressing neurons in the PFC of adult mice. We found that optogenetic stimulation of PFC 5-HT 2A R expressing neurons in the absence of an agonist does not increase HTRs in mice. In both male and female Ai32 mice that received vehicle, there was no difference in HTRs in mice that expressed Htr2a -Cre compared with control mice, indicating that optogenetic activation of 5-HT 2A R+ cells in the PFC was not sufficient to produce HTRs in the absence of an agonist. In female mice, activation of PFC 5-HT 2A R expressing neurons augmented the HTR produced by DOI. However, this result was not seen in male mice. In contrast, inhibition of 5-HT 2A R expressing neurons in the PFC prevented the increase in HTR produced by DOI in male, but not in female, mice. Together, these findings suggest that activation of 5-HT 2A Rs in the PFC is not sufficient to induce HTRs in the absence of a 5-HT 2A R agonist but is necessary for induction of HTRs by a 5-HT 2A R agonist in a sex-dependent manner.
- Open Access
- 27 March 2024
- Published by Elsevier in Data in Brief
- Vol. 54, 110365
Data on electroconvulsive seizure in mice, effects of anesthesia on immediate early gene expression
- 27 March 2024
- Published by Elsevier in Data in Brief
- Vol. 54, 110365
Open AccessData on electroconvulsive seizure in mice, effects of anesthesia on immediate early gene expression
- Open Access
- 3 May 2023
- Published by Elsevier in Brain Stimulation
- Vol. 16 (3) , 889-900
Serial electroconvulsive Seizure alters dendritic complexity and promotes cellular proliferation in the mouse dentate gyrus; a role for Egr3
- 3 May 2023
- Published by Elsevier in Brain Stimulation
- Vol. 16 (3) , 889-900
Open AccessSerial electroconvulsive Seizure alters dendritic complexity and promotes cellular proliferation in the mouse dentate gyrus; a role for Egr3
- Open Access
- 8 August 2022
- Published by Springer Nature in Translational Psychiatry
- Vol. 12 (1) , 1-17
Identification of activity-induced Egr3-dependent genes reveals genes associated with DNA damage response and schizophrenia
Bioinformatics and network studies have identified the immediate early gene transcription factor early growth response 3 (EGR3) as a master regulator of genes differentially expressed in the brains of patients with neuropsychiatric illnesses ranging from schizophrenia and bipolar disorder to Alzheimer’s disease. However, few studies have identified and validatedEgr3-dependent genes in the mammalian brain. We have previously shown thatEgr3is required for stress-responsive behavior, memory, and hippocampal long-term depression in mice. To identifyEgr3-dependent genes that may regulate these processes, we conducted an expression microarray on hippocampi from wildtype (WT) andEgr3−/−mice following electroconvulsive seizure (ECS), a stimulus that induces maximal expression of immediate early genes includingEgr3. We identified 69 genes that were differentially expressed between WT andEgr3−/−mice one hour following ECS. Bioinformatic analyses showed that many of these are altered in, or associated with, schizophrenia, includingMef2candCalb2. Enrichr pathway analysis revealed the GADD45 (growth arrest and DNA-damage-inducible) family (Gadd45b,Gadd45g) as a leading group of differentially expressed genes. Together with differentially expressed genes in the AP-1 transcription factor family genes (Fos,Fosb), and the centromere organization proteinCenpa, these results revealed thatEgr3is required for activity-dependent expression of genes involved in the DNA damage response. Our findings show thatEGR3is critical for the expression of genes that are mis-expressed in schizophrenia and reveal a novel requirement for EGR3 in the expression of genes involved in activity-induced DNA damage response.
- 8 August 2022
- Published by Springer Nature in Translational Psychiatry
- Vol. 12 (1) , 1-17
Open AccessIdentification of activity-induced Egr3-dependent genes reveals genes associated with DNA damage response and schizophrenia
Bioinformatics and network studies have identified the immediate early gene transcription factor early growth response 3 (EGR3) as a master regulator of genes differentially expressed in the brains of patients with neuropsychiatric illnesses ranging from schizophrenia and bipolar disorder to Alzheimer’s disease. However, few studies have identified and validatedEgr3-dependent genes in the mammalian brain. We have previously shown thatEgr3is required for stress-responsive behavior, memory, and hippocampal long-term depression in mice. To identifyEgr3-dependent genes that may regulate these processes, we conducted an expression microarray on hippocampi from wildtype (WT) andEgr3−/−mice following electroconvulsive seizure (ECS), a stimulus that induces maximal expression of immediate early genes includingEgr3. We identified 69 genes that were differentially expressed between WT andEgr3−/−mice one hour following ECS. Bioinformatic analyses showed that many of these are altered in, or associated with, schizophrenia, includingMef2candCalb2. Enrichr pathway analysis revealed the GADD45 (growth arrest and DNA-damage-inducible) family (Gadd45b,Gadd45g) as a leading group of differentially expressed genes. Together with differentially expressed genes in the AP-1 transcription factor family genes (Fos,Fosb), and the centromere organization proteinCenpa, these results revealed thatEgr3is required for activity-dependent expression of genes involved in the DNA damage response. Our findings show thatEGR3is critical for the expression of genes that are mis-expressed in schizophrenia and reveal a novel requirement for EGR3 in the expression of genes involved in activity-induced DNA damage response.
- 10 January 2022
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (3) , 1599-1610
Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3
Serotonin 2A receptors (5-HT2ARs) mediate the hallucinogenic effects of psychedelic drugs and are a key target of the leading class of medications used to treat psychotic disorders. These findings suggest that dysfunction of 5-HT2ARs may contribute to the symptoms of schizophrenia, a mental illness characterized by perceptual and cognitive disturbances. Indeed, numerous studies have found that 5-HT2ARs are reduced in the brains of individuals with schizophrenia. However, the mechanisms that regulate 5-HT2AR expression remain poorly understood. Here, we show that a physiologic environmental stimulus, sleep deprivation, significantly upregulates 5-HT2AR levels in the mouse frontal cortex in as little as 6–8 h (for mRNA and protein, respectively). This induction requires the activity-dependent immediate early gene transcription factor early growth response 3 (Egr3) as it does not occur in Egr3 deficient (−/−) mice. Using chromatin immunoprecipitation, we show that EGR3 protein binds to the promoter of Htr2a, the gene that encodes the 5-HT2AR, in the frontal cortex in vivo, and drives expression of in vitro reporter constructs via two EGR3 binding sites in the Htr2a promoter. These results suggest that EGR3 directly regulates Htr2a expression, and 5-HT2AR levels, in the frontal cortex in response to physiologic stimuli. Analysis of publicly available post-mortem gene expression data revealed that both EGR3 and HTR2A mRNA are reduced in the prefrontal cortex of schizophrenia patients compared to controls. Together these findings suggest a mechanism by which environmental stimuli alter levels of a brain receptor that may mediate the symptoms, and treatment, of mental illness.
- 10 January 2022
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (3) , 1599-1610
Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3
Serotonin 2A receptors (5-HT2ARs) mediate the hallucinogenic effects of psychedelic drugs and are a key target of the leading class of medications used to treat psychotic disorders. These findings suggest that dysfunction of 5-HT2ARs may contribute to the symptoms of schizophrenia, a mental illness characterized by perceptual and cognitive disturbances. Indeed, numerous studies have found that 5-HT2ARs are reduced in the brains of individuals with schizophrenia. However, the mechanisms that regulate 5-HT2AR expression remain poorly understood. Here, we show that a physiologic environmental stimulus, sleep deprivation, significantly upregulates 5-HT2AR levels in the mouse frontal cortex in as little as 6–8 h (for mRNA and protein, respectively). This induction requires the activity-dependent immediate early gene transcription factor early growth response 3 (Egr3) as it does not occur in Egr3 deficient (−/−) mice. Using chromatin immunoprecipitation, we show that EGR3 protein binds to the promoter of Htr2a, the gene that encodes the 5-HT2AR, in the frontal cortex in vivo, and drives expression of in vitro reporter constructs via two EGR3 binding sites in the Htr2a promoter. These results suggest that EGR3 directly regulates Htr2a expression, and 5-HT2AR levels, in the frontal cortex in response to physiologic stimuli. Analysis of publicly available post-mortem gene expression data revealed that both EGR3 and HTR2A mRNA are reduced in the prefrontal cortex of schizophrenia patients compared to controls. Together these findings suggest a mechanism by which environmental stimuli alter levels of a brain receptor that may mediate the symptoms, and treatment, of mental illness.
- Open Access
Identification of activity-induced Egr3 -dependent genes reveals genes associated with DNA damage response and schizophrenia
Bioinformatics and network studies have identified the immediate early gene transcription factor early growth response 3 (EGR3) as a master regulator of genes differentially expressed in the brains of patients with neuropsychiatric illnesses ranging from schizophrenia and bipolar disorder to Alzheimer’s disease. However, few studies have identified and validated Egr3 -dependent genes in the mammalian brain. We have previously shown that Egr3 is required for stress-responsive behavior, memory, and hippocampal long-term depression in mice. To identify Egr3 -dependent genes that may regulate these processes, we conducted an expression microarray on hippocampi from wildtype (WT) and Egr3-/- mice following electroconvulsive seizure (ECS), a stimulus that induces maximal expression of immediate early genes including Egr3 . We identified 71 genes that were differentially expressed between WT and Egr3-/- mice one hour following ECS. Bioinformatic analyses showed that many of these are altered in schizophrenia. Ingenuity pathway analysis revealed the GADD45 (growth arrest and DNA-damage-inducible) family ( Gadd45b, Gadd45g ) as the leading category of differentially expressed genes. Together with differentially expressed genes in the AP-1 transcription factor family genes ( Fos, Fosb ), and the centromere organization protein Cenpa , these results revealed that Egr3 is required for activity-dependent expression of genes involved in the DNA damage response. Our findings implicate EGR3 as gene critical for the expression of genes that are disrupted in schizophrenia and reveal a novel requirement for EGR3 in the expression of genes involved in activity-induced DNA damage response.
Open AccessIdentification of activity-induced Egr3 -dependent genes reveals genes associated with DNA damage response and schizophrenia
Bioinformatics and network studies have identified the immediate early gene transcription factor early growth response 3 (EGR3) as a master regulator of genes differentially expressed in the brains of patients with neuropsychiatric illnesses ranging from schizophrenia and bipolar disorder to Alzheimer’s disease. However, few studies have identified and validated Egr3 -dependent genes in the mammalian brain. We have previously shown that Egr3 is required for stress-responsive behavior, memory, and hippocampal long-term depression in mice. To identify Egr3 -dependent genes that may regulate these processes, we conducted an expression microarray on hippocampi from wildtype (WT) and Egr3-/- mice following electroconvulsive seizure (ECS), a stimulus that induces maximal expression of immediate early genes including Egr3 . We identified 71 genes that were differentially expressed between WT and Egr3-/- mice one hour following ECS. Bioinformatic analyses showed that many of these are altered in schizophrenia. Ingenuity pathway analysis revealed the GADD45 (growth arrest and DNA-damage-inducible) family ( Gadd45b, Gadd45g ) as the leading category of differentially expressed genes. Together with differentially expressed genes in the AP-1 transcription factor family genes ( Fos, Fosb ), and the centromere organization protein Cenpa , these results revealed that Egr3 is required for activity-dependent expression of genes involved in the DNA damage response. Our findings implicate EGR3 as gene critical for the expression of genes that are disrupted in schizophrenia and reveal a novel requirement for EGR3 in the expression of genes involved in activity-induced DNA damage response.
- Open Access
- 21 February 2020
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 14, 16
Editorial: The Role of Immediate Early Genes in Neuropsychiatric Illness
Editorial: The Role of Immediate Early Genes in Neuropsychiatric Illness
- 21 February 2020
- Published by Frontiers Media SA in Frontiers in Behavioral Neuroscience
- Vol. 14, 16
Open AccessEditorial: The Role of Immediate Early Genes in Neuropsychiatric Illness
Editorial: The Role of Immediate Early Genes in Neuropsychiatric Illness